Showing results (971-980 of 1,000) with videos related to

Sort By:
Pageof 100
Clinical Colorectal Cancer|August 15, 2016
Neutropenia as a Predictive Factor in Metastatic Colorectal Cancer Treated With TAS-102Satoshi Hamauchi, Kentaro Yamazaki, Toshiki Masuishi, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|April 5, 2016
Severe or life-threatening asthma exacerbation: patient heterogeneity identified by cluster analysisK Sekiya, E Nakatani, Y Fukutomi, et al.
Pancreas|December 28, 2020
Tolerability of Nab-Paclitaxel Plus Gemcitabine as Adjuvant Setting in Japanese Patients With Resected Pancreatic Cancer: Phase I StudyMakoto Ueno, Soichiro Morinaga, Yusuke Hashimoto, et al.
The Journal of Biological Chemistry|September 3, 2010
Human sodium phosphate transporter 4 (hNPT4/SLC17A3) as a common renal secretory pathway for drugs and uratePromsuk Jutabha, Naohiko Anzai, Kenichiro Kitamura, et al.
Allergy|December 3, 2017
Identification of patterns of factors preceding severe or life-threatening asthma exacerbations in a nationwide studyH Tanaka, E Nakatani, Y Fukutomi, et al.
Arerugi = [Allergy]|June 29, 2002
[Evaluation before and after pranlukast administration with the QOL questionnaire (revised version 2001) for pediatric patients with bronchial asthma and their parents or caregivers]Naomi Kondo, Takahide Teramoto, Ryosuke Inoue, et al.
BMJ Open|April 22, 2015
Prevalence of hypertension at high altitude: cross-sectional survey in Ladakh, Northern India 2007-2011Tsering Norboo, Tsering Stobdan, Norboo Tsering, et al.
Cancer Medicine|February 26, 2021
A randomized, double-blind, phase II study of oral histone deacetylase inhibitor resminostat plus S-1 versus placebo plus S-1 in biliary tract cancers previously treated with gemcitabine plus platinum-based chemotherapyMakoto Ueno, Chigusa Morizane, Masayuki Furukawa, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 18, 2024
High serum growth differentiation factor 15 is a risk factor for the occurrence of hepatocellular carcinoma in chronic hepatitis B patients treated with nucleos(t)ide analogsEmi Sometani, Hayato Hikita, Kazuhiro Murai, et al.
The Kurume Medical Journal|July 30, 2023
Preoperative Chemotherapy Followed by Hepatectomy for Potentially Resectable UICC7 Stage IIIA, IIIB Hepatocellular Carcinoma; A Phase II Clinical TrialYuichi Goto, Takashi Niizeki, Shogo Fukutomi, et al.
Pageof 100